Herald Sun’s In The Black columnist, John Beveridge reported on Starpharma and its collaboration with Nufarm and Israel’s Makhreshim Agan, trading in Australia as Farmoz. These collaborations are a vote of confidence to the versatility of Starpharma’s dendrimer technology. "Dendrimers, nanoparticles that can greatly improve water solubility, are ideally suited to improving farming chemicals. In the case of weedkillers such as glyphosate, the addition of the right sort of dendrimer at the right levels can make the weedkiller much faster and more effective to use and able to be applied close to rain. For other agricultural chemicals the advantage is even greater, allowing the removal of dangerous solvents used to make theactive ingredient soluble and allowing the production of concentrates that are much easier to transport and can be mixed with water on site."

Starpharma Holdings Ltd and Makhteshim Agan Group today announced a collaboration program. This will see Starpharma’s Priostar® dendrimer technology applied to novel crop protection formulations across Makhteshim Agan’s extensive product portfolio.

Herald Sun reporters Brigid O’Connell, Lucie van den Berg and Grant McArthur featured Starpharma in a special report in The Herald Sun and The Australian online, examining cutting edge medical research being done in Melbourne.

"The home of corporate giants CSL, Mesoblast, Acrux, Biota and Starpharma, Melbourne also dominates in taking the laboratory to the marketplace: more than 85 products were on the market last year and dozens more were in trials in hopes of delivering the next generation of medical advances."

Starpharma today announced the results of an animal study which shows that a dendrimer-based formulation of doxorubicin was substantially more efficacious in treating secondary tumours of breast cancer (metastases) in lungs than the drug alone.